XML 75 R31.htm IDEA: XBRL DOCUMENT v3.19.3
RESTATEMENT OF CONSOLIDATED FINANCIAL STATEMENTS (Tables)
12 Months Ended
Jun. 30, 2019
Accounting Changes and Error Corrections [Abstract]  
RESTATEMENT OF CONSOLIDATED FINANCIAL STATEMENTS
A summary of the impact of these matters on income (loss) before taxes is presented below:
($ in thousands)
Increase / (Decrease) Restatement Impact
 
Year ended June 30, 2017
Audit Committee Investigation-related Adjustments:
 
Revenue
$
(2,568
)
Costs of sales
$
(1,163
)
Gross profit
$
(1,405
)
Operating income (loss)
$
(1,405
)
Loss before income taxes
$
(1,405
)
 
 
Significant Account and Transaction Review and Other:
 
Revenue
$
(89
)
Costs of sales
$
91

Gross profit
$
(180
)
Operating income (loss)
$
(2,864
)
Loss before income taxes
$
(4,200
)
A summary of the impact of these matters on the consolidated balance sheet is presented below, excluding any tax effect from the restatement adjustments in the aggregate:
($ in thousands)
Increase / (Decrease) Restatement Impact
 
As of June 30, 2017
Audit Committee Investigation-related Adjustments:
 
Accounts receivable
$
(284
)
Finance receivables, net
$
(1,267
)
Inventory, net
$
1,106

Prepaid expenses and other current assets
$
25

Other assets
$
88

Accounts payable
$
270

Accrued expenses
$
803

 
 
Significant Account and Transaction Review and Other:
 
Accounts receivable
$
(75
)
Inventory, net
$
(500
)
Prepaid expenses and other current assets
$
(114
)
Other assets
$
(456
)
Property and equipment, net
$
(1,000
)
Accounts payable
$
21

Accrued expenses
$
7,235

Capital lease obligation and current obligations under long-term debt
$
(32
)
Deferred revenue
$
(27
)
Deferred gain from sale-leaseback transactions
$
(239
)
Deferred gain from sale-leaseback transactions, less current portion
$
(100
)
The effect of the restatement on the previously filed consolidated balance sheet as of June 30, 2017 is as follows:
 
As of June 30, 2017
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Assets
 
 
 
 
 
Current assets:
 
 
 
 
 
Cash and cash equivalents
$
12,745

 
$

 
$
12,745

Accounts receivable
7,193

 
(359
)
 
6,834

Finance receivables, net
11,010

 
(1,267
)
 
9,743

Inventory, net
4,586

 
606

 
5,192

Prepaid expenses and other current assets
968

 
(89
)
 
879

Total current assets
36,502

 
(1,109
)
 
35,393

 
 
 
 
 
 
Non-current assets:
 
 
 
 
 
Finance receivables due after one year
8,607

 

 
8,607

Other assets
687

 
(368
)
 
319

Property and equipment, net
12,111

 
(1,000
)
 
11,111

Deferred income taxes
27,670

 
(27,670
)
 

Intangibles, net
622

 

 
622

Goodwill
11,492

 

 
11,492

Total non-current assets
61,189

 
(29,038
)
 
32,151

 
 
 
 
 
 
Total assets
$
97,691

 
$
(30,147
)
 
$
67,544

 
 
 
 
 
 
Liabilities, convertible preferred stock and shareholders’ equity
 
 
 
 
 
Current liabilities:
 
 
 
 
 
Accounts payable
$
16,054

 
$
291

 
$
16,345

Accrued expenses
4,130

 
7,743

 
11,873

Line of credit, net
7,036

 

 
7,036

Capital lease obligations and current obligations under long-term debt
3,230

 
(32
)
 
3,198

Income taxes payable
10

 

 
10

Deferred revenue

 
268

 
268

Deferred gain from sale-leaseback transactions
239

 
(239
)
 

Total current liabilities
30,699

 
8,031

 
38,730

 
 
 
 
 
 
Long-term liabilities:
 
 
 
 
 
Deferred income taxes

 
94

 
94

Capital lease obligations and long-term debt, less current portion
1,061

 

 
1,061

Accrued expenses, less current portion
53

 

 
53

Deferred gain from sale-leaseback transactions, less current portion
100

 
(100
)
 

Total long-term liabilities
1,214

 
(6
)
 
1,208

 
 
 
 
 
 
Total liabilities
$
31,913

 
$
8,025

 
$
39,938

Commitments and contingencies


 


 


Convertible preferred stock:
 
 
 
 
 
Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $18,775 at June 30, 2017

 
3,138

 
3,138

Shareholders’ equity:
 
 
 
 
 
Preferred stock, no par value, 1,800,000 shares authorized, no shares issued

 

 

Series A convertible preferred stock, 900,000 shares authorized, 445,063 issued and outstanding, with liquidation preference of $18,775 at June 30, 2017
3,138

 
(3,138
)
 

Common stock, no par value, 640,000,000 shares authorized, 40,331,645 shares issued and outstanding at June 30, 2017
245,999

 

 
245,999

Accumulated deficit
(183,359
)
 
(38,172
)
 
(221,531
)
Total shareholders’ equity
65,778

 
(41,310
)
 
24,468

Total liabilities, convertible preferred stock and shareholders’ equity
$
97,691

 
$
(30,147
)
 
$
67,544

The effect of the restatement on the previously filed consolidated statement of operations for the year ended June 30, 2017 is as follows:
 
Year ended June 30, 2017
($ in thousands, except per share data)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
Revenue:
 
 
 
 
 
License and transaction fees
$
69,142

 
$
(8
)
 
$
69,134

Equipment sales
34,951

 
(2,649
)
 
32,302

Total revenue
104,093

 
(2,657
)
 
101,436

 
 
 
 
 
 
Costs of sales:
 
 
 
 
 
Cost of services
47,053

 
(533
)
 
46,520

Cost of equipment
30,394

 
(539
)
 
29,855

Total costs of sales
77,447

 
(1,072
)
 
76,375

Gross profit
26,646

 
(1,585
)
 
25,061

 
 
 
 
 
 
Operating expenses:
 
 
 
 
 
Selling, general and administrative
25,493

 
2,684

 
28,177

Depreciation and amortization
1,018

 

 
1,018

Total operating expenses
26,511

 
2,684

 
29,195

Operating income (loss)
135

 
(4,269
)
 
(4,134
)
 
 
 
 
 
 
Other income (expense):
 
 
 
 
 
Interest income
482

 

 
482

Interest expense
(892
)
 
(1,336
)
 
(2,228
)
Change in fair value of warrant liabilities
(1,490
)
 

 
(1,490
)
Total other expense, net
(1,900
)
 
(1,336
)
 
(3,236
)
 
 
 
 
 
 
Loss before income taxes
(1,765
)
 
(5,605
)
 
(7,370
)
Provision for income taxes
(87
)
 
(8
)
 
(95
)
 
 
 
 
 
 
Net loss
(1,852
)
 
(5,613
)
 
(7,465
)
Preferred dividends
(668
)
 

 
(668
)
Net loss applicable to common shares
$
(2,520
)
 
$
(5,613
)
 
$
(8,133
)
Net loss per common share
 
 
 
 
 
Basic
$
(0.06
)
 
$
(0.14
)
 
$
(0.20
)
Diluted
$
(0.06
)
 
$
(0.14
)
 
$
(0.20
)
Weighted average number of common shares outstanding
 
 
 
 
 
Basic
39,860,335

 

 
39,860,335

Diluted
39,860,335

 

 
39,860,335

The effect of the restatement on the previously filed consolidated statement of cash flows for the year ended June 30, 2017 is as follows:
 
Year ended June 30, 2017
($ in thousands)
As Previously Reported
 
Adjustments
 
As Restated
 
 
 
 
 
 
OPERATING ACTIVITIES:
 
 
 
 
 
Net loss
$
(1,852
)
 
$
(5,613
)
 
$
(7,465
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
 
 
Non-cash stock-based compensation
1,214

 

 
1,214

(Gain) loss on disposal of property and equipment
(177
)
 

 
(177
)
Non-cash interest and amortization of debt discount
113

 

 
113

Bad debt expense
764

 
(207
)
 
557

Provision for inventory reserve

 
877

 
877

Depreciation and amortization
5,591

 
365

 
5,956

Change in fair value of warrant liabilities
1,490

 

 
1,490

Deferred income taxes, net
54

 
8

 
62

Recognition of deferred gain from sale-leaseback transactions
(560
)
 
560

 

Changes in operating assets and liabilities:
 
 
 
 
 
Accounts receivable
(2,988
)
 
450

 
(2,538
)
Finance receivables, net
(12,119
)
 
1,287

 
(10,832
)
Inventory, net
(2,399
)
 
(2,064
)
 
(4,463
)
Prepaid expenses and other current assets
(304
)
 
457

 
153

Accounts payable and accrued expenses
4,410

 
4,464

 
8,874

Deferred revenue

 
115

 
115

Income taxes payable
(8
)
 

 
(8
)
Net cash used in operating activities
(6,771
)
 
699

 
(6,072
)
 
 
 
 
 
 
INVESTING ACTIVITIES:
 
 
 
 
 
Purchase of property and equipment, including rentals
(4,041
)
 
254

 
(3,787
)
Proceeds from sale of property and equipment
348

 

 
348

Net cash used in investing activities
(3,693
)
 
254

 
(3,439
)
 
 
 
 
 
 
FINANCING ACTIVITIES:
 
 
 
 
 
Cash used in retirement of common stock
(31
)
 

 
(31
)
Proceeds from exercise of common stock warrants
6,193

 

 
6,193

Payment of debt issuance costs
(90
)
 

 
(90
)
Repayment of line of credit
(106
)
 

 
(106
)
Repayment of capital lease obligations and long-term debt
(2,029
)
 
(953
)
 
(2,982
)
Net cash provided by financing activities
3,937

 
(953
)
 
2,984

 
 
 
 
 
 
Net decrease in cash and cash equivalents
(6,527
)
 

 
(6,527
)
Cash and cash equivalents at beginning of year
19,272

 

 
19,272

Cash and cash equivalents at end of year
$
12,745

 
$

 
$
12,745